Suling Huang
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
SIK1 drives lipid-induced insulin resistance in skeletal muscle by linking TGFβ1-Smad2/3 activation to PDE4-cAMP dysregulation.
Journal: Molecular and cellular endocrinology
Published: February 03, 2026
Cassane diterpenoids with hepatic gluconeogenesis inhibitory activity from the seeds of Caesalpinia decapetala (Roth) Alston.
Journal: Phytochemistry
Published: January 21, 2025
Activation of SIK1 by phanginin A regulates skeletal muscle glucose uptake by phosphorylating HADC4/5/7 and enhancing GLUT4 expression and translocation.
Journal: Natural products and bioprospecting
Published: December 17, 2024
Design, synthesis and biological evaluation of Alisol B derivatives for potential treatment of non-alcoholic steatohepatitis.
Journal: Bioorganic chemistry
Published: September 11, 2024
Phenotypic screening-based drug discovery of furan-2-carboxylic acid derivatives for the amelioration of type 2 diabetes mellitus (T2DM).
Journal: European journal of medicinal chemistry
Published: October 14, 2022
Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Journal: Nutrients
Published: May 09, 2022
Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.
Journal: Clinical science (London, England : 1979)
Published: June 08, 2021
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.
Journal: Signal transduction and targeted therapy
Published: September 26, 2020
TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Journal: Metabolism: clinical and experimental
Published: March 13, 2019
Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3.
Journal: Frontiers in pharmacology
Published: November 15, 2017
Last Updated: 09/26/2026